Vivus, Inc. recalls PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campb
Recalled July 19, 2023 · FDA recall D-0896-2023 · Vivus
Hazard
Failed Stability Specifications · FDA Class III
Units
4240 bottles
Sold at
Nationwide within the United States
Description
Failed Stability Specifications
Product
PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: N3 62541-401-10 5, NDC 62541-401-10,
Manufacturer(s)
Vivus, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →